Cadrenal Therapeutics, Inc.
CVKD
$5.32
$0.132.51%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/7/2026
-
Globe Newswire
4/30/2026
-
Globe Newswire
4/30/2026
-
Ticker Report
4/21/2026
-
TipRanks Financial Blog
4/21/2026
-
Insider Monkey
4/20/2026
-
Insider Monkey
4/20/2026
-
Insider Monkey
4/7/2026
-
TipRanks Financial Blog
4/1/2026
-
TipRanks Financial Blog
3/31/2026
-
Globe Newswire
3/29/2026
-
Ticker Report
3/13/2026
-
Globe Newswire
3/13/2026
-
Ticker Report
3/12/2026
-
The Fly
3/12/2026
-
Globe Newswire
3/10/2026
-
Globe Newswire
3/2/2026
-
Globe Newswire
2/24/2026
-
The Fly
2/24/2026
-
Globe Newswire
2/18/2026
-
Ticker Report
1/20/2026
-
Stocktwits News Feed
1/12/2026
-
GuruFocus
1/12/2026
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 31, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
904 300 0701
Address
822 A1A North
Ponte Vedra, FL 32082
Ponte Vedra, FL 32082
Country
Year Founded
Business Description
Sector
Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions. The company is developing...
more